​

Clorox (CLX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CLX Stock Forecast

Clorox stock forecast is as follows: an average price target of $159.50 (represents a 1.07% upside from CLX’s last price of $157.81) and a rating consensus of 'Hold', based on 21 wall street analysts offering a 1-year stock forecast.

CLX Price Target

The average price target for Clorox (CLX) is $159.50 based on 1-year price targets from 21 Wall Street analysts in the past 3 months, with a price target range of $187.00 to $132.00. This represents a potential 1.07% upside from CLX's last price of $157.81.

CLX Analyst Ratings

Hold

According to 21 Wall Street analysts, Clorox's rating consensus is 'Hold'. The analyst rating breakdown for CLX stock is 0 'Strong Buy' (0.00%), 8 'Buy' (38.10%), 9 'Hold' (42.86%), 4 'Sell' (19.05%), and 0 'Strong Sell' (0.00%).

Clorox Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 08, 2024Bonnie HerzogGoldman Sachs$132.00$159.56-17.28%-16.36%
Oct 01, 2024Kaumil GajrawalaJefferies$187.00$165.8312.77%18.50%
Jul 19, 2024Lauren LiebermanBarclays$122.00$136.31-10.50%-22.69%
May 02, 2024Chris CareyWells Fargo$135.00$139.63-3.32%-14.45%
Mar 26, 2024Kaumil GajrawalaJefferies$145.00$150.52-3.67%-8.12%
Jan 30, 2024Nik ModiRBC Capital$138.00$145.97-5.46%-12.55%
Oct 05, 2023Olivia TongRaymond James$185.00$124.6948.37%17.23%
Sep 08, 2023Ken GoldmanJ.P. Morgan$153.00$155.10-1.35%-3.05%
Feb 03, 2023Morgan Stanley$145.00$141.002.84%-8.12%
Feb 03, 2023Raymond James$165.00$141.0017.02%4.56%
Feb 01, 2023Jefferies$145.00$143.321.17%-8.12%
Jan 03, 2023Wells Fargo$135.00$140.39-3.84%-14.45%
Dec 06, 2022Deutsche Bank$151.00$146.702.93%-4.32%
Aug 19, 2022Barclays$101.00$148.71-32.08%-36.00%
Jul 12, 2022Olivia TongRaymond James$160.00$143.8911.20%1.39%
May 03, 2022D.A. Davidson$123.00$147.56-16.64%-22.06%
May 03, 2022Morgan Stanley$137.00$143.28-4.38%-13.19%
May 03, 2022Wells Fargo$130.00$143.28-9.27%-17.62%
Apr 29, 2022Lauren LiebermanBarclays$117.00$148.34-21.13%-25.86%
Apr 29, 2022Andrea Faria TeixeiraJ.P. Morgan$126.00$148.34-15.06%-20.16%
Apr 24, 2022Steve PowersDeutsche Bank$146.00$150.65-3.09%-7.48%
Feb 08, 2022Linda Bolton WeiserD.A. Davidson$127.00$143.22-11.33%-19.52%
Feb 04, 2022Peter GromUBS$148.00$141.414.66%-6.22%
Feb 02, 2022Callum ElliottBernstein$155.00$166.99-7.18%-1.78%
Jan 26, 2022Kaumil GajrawalaCredit Suisse$160.00$164.72-2.87%1.39%
Jan 05, 2022Kevin GrundyJefferies$185.00$176.274.95%17.23%

The latest Clorox stock forecast, released on Oct 08, 2024 by Bonnie Herzog from Goldman Sachs, set a price target of $132.00, which represents a -17.28% decrease from the stock price at the time of the forecast ($159.56), and a -16.36% decrease from CLX last price ($157.81).

Clorox Price Target by Period

1M3M12M
# Anlaysts--6
Avg Price Target--$143.17
Last Closing Price$157.81$157.81$157.81
Upside/Downside-100.00%-100.00%-9.28%

In the current month, the average price target of Clorox stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Clorox's last price of $157.81. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Jan 08, 2025Wells FargoBuyNegativeUpgrade
Oct 11, 2024BarclaysUnderweightUnderweightHold
Oct 08, 2024Goldman SachsSellSellHold
Oct 01, 2024Wells FargoBuyBuyHold
Oct 01, 2024JefferiesHoldBuyUpgrade
Aug 28, 2024CitigroupNeutralNeutralHold
Jul 22, 2024Cowen & Co.SellBuyInitialise
Jul 22, 2024Cowen & Co.SellInitialise
Jul 19, 2024BarclaysUnderweightUnderweightHold
Jul 10, 2024CitigroupNeutralNeutralHold
Jun 24, 2024Wells FargoHoldHoldHold
Jun 24, 2024Exane BNP ParibasUnderperformInitialise
May 02, 2024Wells FargoUnderweightUnderweightHold
Apr 16, 2024UBSEqual-WeightEqual-WeightHold
Apr 02, 2024CitigroupBuyNeutralDowngrade
Jan 30, 2024RBC CapitalSector PerformSector PerformHold
Dec 15, 2023Bank of America SecuritiesNeutralUpgrade
Nov 22, 2023RBC CapitalNeutralUpgrade
Nov 06, 2023UBSSellNeutralUpgrade
Nov 02, 2023Piper SandlerNeutralNeutralHold
Nov 02, 2023CitigroupBuyUpgrade
Oct 12, 2023BernsteinMarket PerformUpgrade
Oct 02, 2023BTIGNeutralUpgrade
Oct 02, 2023Morgan StanleyEqual-WeightOverweightUpgrade
Oct 02, 2023Wells FargoUnderweightEqual-WeightDowngrade
Oct 02, 2023BarclaysUnderweightEqual-WeightDowngrade
Sep 19, 2023Wells FargoUnderweightUnderweightHold
Sep 08, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Aug 07, 2023Morgan StanleyNeutralNeutralHold
Aug 03, 2023Atlantic EquitiesNeutralUpgrade
Feb 06, 2023BarclaysUnderweightUnderweightHold
Feb 03, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Feb 01, 2023JefferiesHoldHoldHold
Jan 03, 2023Wells FargoUnderweightUnderweightHold
Dec 06, 2022Deutsche BankHoldHoldHold
Nov 02, 2022Credit SuisseUnderperformUnderperformHold
Oct 18, 2022UBSSellSellHold
Oct 18, 2022Evercore PartnersBuyInitialise
Oct 17, 2022Prescience PointBuyPositiveUpgrade
Oct 17, 2022Keefe, Bruyette & WoodsOutperformUpgrade
Oct 17, 2022Prescience PointBuyUpgrade
Sep 13, 2022Wells FargoUnderweightUnderweightHold
Aug 19, 2022BarclaysUnderweightUnderweightHold
Jul 12, 2022Raymond JamesOutperformInitialise
Apr 29, 2022J.P. MorganSellSellHold
Apr 29, 2022BarclaysSellSellHold
Apr 24, 2022Deutsche BankHoldHoldHold
Jan 26, 2022Credit SuisseUnderperformDowngrade
Nov 03, 2020D.A. DavidsonBuyBuyHold

Clorox's last stock rating was published by Wells Fargo on Jan 08, 2025. The company Upgrade its CLX rating from "Buy" to "Negative".

Clorox Financial Forecast

Clorox Revenue Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Revenue------------------$1.99B$1.39B$2.02B$1.92B$1.72B$1.74B$1.80B$1.81B$1.69B$1.81B$1.80B$1.78B
Avg Forecast$2.17B$2.02B$1.86B$1.94B$2.03B$1.89B$1.76B$1.83B$1.96B$1.82B$1.70B$1.78B$1.89B$1.77B$1.63B$1.65B$1.95B$1.87B$1.80B$1.31B$1.88B$1.82B$1.66B$1.69B$1.86B$1.79B$1.67B$1.70B$1.91B$1.86B
High Forecast$2.21B$2.05B$1.90B$1.97B$2.06B$1.92B$1.79B$1.86B$1.99B$1.85B$1.73B$1.81B$1.93B$1.81B$1.66B$1.65B$1.95B$1.87B$1.82B$1.37B$1.91B$1.85B$1.72B$1.69B$1.86B$1.79B$1.67B$1.70B$1.91B$1.86B
Low Forecast$2.12B$1.97B$1.82B$1.90B$1.98B$1.84B$1.72B$1.79B$1.91B$1.78B$1.66B$1.74B$1.85B$1.72B$1.57B$1.65B$1.95B$1.87B$1.77B$1.27B$1.83B$1.78B$1.62B$1.69B$1.86B$1.79B$1.67B$1.70B$1.91B$1.86B
# Analysts435454545443488433696437434744
Surprise %------------------1.10%1.06%1.08%1.05%1.03%1.03%0.97%1.01%1.01%1.06%0.95%0.96%

Clorox's average Quarter revenue forecast for Mar 24 based on 3 analysts is $1.87B, with a low forecast of $1.87B, and a high forecast of $1.87B. CLX's average Quarter revenue forecast represents a -6.04% decrease compared to the company's last Quarter revenue of $1.99B (Dec 23).

Clorox EBITDA Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts435454545443488433696437434744
EBITDA------------------$390.00M$227.00M$258.00M$224.00M$153.00M$194.00M$166.00M$278.00M$168.00M$264.00M$177.00M$17.00M
Avg Forecast$300.44M$279.89M$258.48M$268.93M$281.02M$261.45M$243.59M$253.26M$271.08M$252.62M$235.87M$247.20M$262.67M$244.93M$225.45M$228.47M$270.13M$216.90M$250.10M$181.16M$260.03M$197.18M$224.40M$250.31M$275.68M$179.26M$246.57M$250.86M$281.79M$15.39M
High Forecast$305.69M$284.79M$262.99M$273.63M$285.93M$266.02M$247.84M$257.68M$275.82M$257.03M$240.00M$251.52M$267.26M$250.44M$229.58M$228.48M$270.13M$260.28M$252.91M$189.93M$264.58M$236.62M$269.28M$250.31M$275.68M$215.11M$246.57M$250.86M$281.79M$18.47M
Low Forecast$293.72M$273.63M$252.69M$262.91M$274.73M$255.60M$238.13M$247.59M$265.01M$246.96M$230.59M$241.66M$256.79M$238.05M$217.20M$228.45M$270.13M$173.52M$245.89M$176.00M$254.21M$157.75M$179.52M$250.31M$275.68M$143.41M$246.57M$250.86M$281.79M$12.31M
Surprise %------------------1.56%1.25%0.99%1.14%0.68%0.78%0.60%1.55%0.68%1.05%0.63%1.10%

3 analysts predict CLX's average Quarter EBITDA for Mar 24 to be $216.90M, with a high of $260.28M and a low of $173.52M. This is -44.38% lower than Clorox's previous annual EBITDA (Dec 23) of $390.00M.

Clorox Net Income Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts435454545443488433696437434744
Net Income------------------$93.00M$22.00M$176.00M$-209.00M$99.00M$85.00M$101.00M$150.00M$72.00M$142.00M$97.00M$-61.00M
Avg Forecast----$271.50M$234.13M$205.78M$229.67M$255.30M$218.49M$193.67M$233.73M$241.98M$203.92M$174.39M$176.14M$193.80M$117.88M$136.23M$-30.25M$145.57M$107.16M$92.16M$92.96M$115.97M$97.42M$99.41M$129.02M$164.52M$-55.23M
High Forecast----$277.67M$239.45M$210.45M$234.89M$261.10M$223.45M$198.07M$239.04M$247.48M$210.06M$196.97M$185.21M$193.84M$141.46M$155.15M$-4.12M$147.11M$128.60M$110.60M$92.96M$115.97M$116.91M$99.41M$129.02M$164.52M$-44.18M
Low Forecast----$263.60M$227.32M$199.79M$222.98M$247.87M$212.13M$188.03M$226.92M$234.94M$196.54M$155.57M$167.08M$193.76M$94.31M$122.36M$-55.00M$144.02M$85.73M$73.73M$92.96M$115.97M$77.94M$99.41M$129.02M$164.52M$-66.28M
Surprise %------------------0.68%-0.73%1.21%-1.95%1.07%0.91%0.87%1.54%0.72%1.10%0.59%1.10%

Clorox's average Quarter net income forecast for Mar 24 is $117.88M, with a range of $94.31M to $141.46M. CLX's average Quarter net income forecast represents a 26.75% increase compared to the company's last Quarter net income of $93.00M (Dec 23).

Clorox SG&A Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts435454545443488433696437434744
SG&A------------------$508.00M$276.00M$540.00M$517.00M$438.00M$422.00M$451.00M$386.00M$408.00M$418.00M$484.00M$437.00M
Avg Forecast$548.03M$510.55M$471.48M$490.55M$512.61M$476.91M$444.32M$461.96M$494.47M$460.80M$430.25M$450.91M$479.13M$446.78M$411.24M$416.74M$492.74M$303.35M$456.20M$330.45M$474.32M$275.77M$544.97M$427.37M$470.69M$250.70M$420.98M$428.31M$481.11M$395.66M
High Forecast$557.61M$519.47M$479.72M$499.13M$521.57M$485.24M$452.09M$470.03M$503.12M$468.85M$437.77M$458.79M$487.51M$456.82M$418.77M$416.77M$492.74M$364.02M$461.33M$346.45M$482.61M$330.93M$653.97M$427.37M$470.69M$300.84M$420.98M$428.31M$481.11M$474.79M
Low Forecast$535.77M$499.12M$460.93M$479.57M$501.13M$466.23M$434.38M$451.62M$483.40M$450.48M$420.62M$440.82M$468.41M$434.23M$396.20M$416.71M$492.74M$242.68M$448.52M$321.05M$463.70M$220.62M$435.98M$427.37M$470.69M$200.56M$420.98M$428.31M$481.11M$316.53M
Surprise %------------------1.11%0.84%1.14%1.87%0.80%0.99%0.96%1.54%0.97%0.98%1.01%1.10%

Clorox's average Quarter SG&A projection for Mar 24 is $303.35M, based on 3 Wall Street analysts, with a range of $242.68M to $364.02M. The forecast indicates a -40.29% fall compared to CLX last annual SG&A of $508.00M (Dec 23).

Clorox EPS Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts435454545443488433696437434744
EPS------------------$0.75$0.18$1.43$-1.69$0.81$0.69$0.81$1.22$0.59$1.15$0.79$-0.49
Avg Forecast----$2.18$1.88$1.65$1.84$2.05$1.75$1.55$1.87$1.94$1.64$1.40$1.41$1.55$1.36$1.09$-0.24$1.17$1.23$0.66$0.74$0.93$0.92$0.79$1.03$1.32$1.48
High Forecast----$2.23$1.92$1.69$1.88$2.09$1.79$1.59$1.92$1.98$1.68$1.58$1.49$1.55$1.36$1.24$-0.03$1.18$1.25$0.69$0.74$0.93$0.92$0.79$1.03$1.32$1.48
Low Forecast----$2.11$1.82$1.60$1.79$1.99$1.70$1.51$1.82$1.88$1.58$1.25$1.34$1.55$1.36$0.98$-0.44$1.16$1.19$0.64$0.74$0.93$0.92$0.79$1.03$1.32$1.48
Surprise %------------------0.69%-0.74%1.22%-1.38%1.23%0.93%0.87%1.32%0.74%1.11%0.60%-0.33%

According to 3 Wall Street analysts, Clorox's projected average Quarter EPS for Mar 24 is $1.36, with a low estimate of $1.36 and a high estimate of $1.36. This represents a 81.53% increase compared to CLX previous annual EPS of $0.75 (Dec 23).

Clorox Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ELEstée Lauder Companies$82.28$110.6034.42%Hold
ULUnilever$57.27$72.0025.72%Buy
CLColgate-Palmolive$89.57$110.5023.37%Buy
KMBKimberly-Clark$129.67$151.0016.45%Hold
PGProcter & Gamble$166.23$172.403.71%Buy
CLXClorox$157.81$159.501.07%Hold
CHDChurch & Dwight$106.77$106.20-0.53%Hold

CLX Forecast FAQ

Is Clorox a good buy?

No, according to 21 Wall Street analysts, Clorox (CLX) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 38.10% of CLX's total ratings.

What is CLX's price target?

Clorox (CLX) average price target is $159.5 with a range of $132 to $187, implying a 1.07% from its last price of $157.81. The data is based on 21 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Clorox stock go up soon?

According to Wall Street analysts' prediction for CLX stock, the company can go up by 1.07% (from the last price of $157.81 to the average price target of $159.5), up by 18.50% based on the highest stock price target, and down by -16.36% based on the lowest stock price target.

Can Clorox stock reach $200?

CLX's average twelve months analyst stock price target of $159.5 does not support the claim that Clorox can reach $200 in the near future.

What are Clorox's analysts' financial forecasts?

Clorox's analysts financial forecasts for the fiscal year (Jun 2027) are as follows: average revenue is $7.5B (high $7.63B, low $7.33B), average EBITDA is $1.04B (high $1.06B, low $1.02B), average net income is $941.08M (high $962.46M, low $913.69M), average SG&A $1.9B (high $1.93B, low $1.85B), and average EPS is $7.55 (high $7.72, low $7.33). CLX's analysts financial forecasts for the fiscal year (Jun 2028) are as follows: average revenue is $7.99B (high $8.13B, low $7.81B), average EBITDA is $1.11B (high $1.13B, low $1.08B), average net income is $0 (high $0, low $0), average SG&A $2.02B (high $2.06B, low $1.98B), and average EPS is $0 (high $0, low $0).

Did the CLX's actual financial results beat the analysts' financial forecasts?

Based on Clorox's last annual report (Jun 2023), the company's revenue was $7.39B, beating the average analysts forecast of $7.05B by 4.86%. Apple's EBITDA was $773M, missing the average prediction of $931.93M by -17.05%. The company's net income was $149M, missing the average estimation of $437.85M by -65.97%. Apple's SG&A was $1.92B, beating the average forecast of $1.72B by 11.30%. Lastly, the company's EPS was $1.21, missing the average prediction of $3.8 by -68.13%. In terms of the last quarterly report (Dec 2023), Clorox's revenue was $1.99B, beating the average analysts' forecast of $1.8B by 10.30%. The company's EBITDA was $390M, beating the average prediction of $250.1M by 55.94%. Clorox's net income was $93M, missing the average estimation of $136.23M by -31.73%. The company's SG&A was $508M, beating the average forecast of $456.2M by 11.35%. Lastly, the company's EPS was $0.75, missing the average prediction of $1.09 by -31.36%